283 related articles for article (PubMed ID: 22672777)
21. Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus.
Tarnaris A; Toma AK; Chapman MD; Keir G; Kitchen ND; Watkins LD
J Neurosurg; 2011 Jul; 115(1):145-50. PubMed ID: 21438653
[TBL] [Abstract][Full Text] [Related]
22. CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease.
Perneczky R; Tsolakidou A; Arnold A; Diehl-Schmid J; Grimmer T; Förstl H; Kurz A; Alexopoulos P
Neurology; 2011 Jul; 77(1):35-8. PubMed ID: 21700579
[TBL] [Abstract][Full Text] [Related]
23. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus.
Kazui H; Kanemoto H; Yoshiyama K; Kishima H; Suzuki Y; Sato S; Suehiro T; Azuma S; Yoshimine T; Tanaka T
J Neurol Sci; 2016 Oct; 369():236-241. PubMed ID: 27653897
[TBL] [Abstract][Full Text] [Related]
24. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.
Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P
J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350
[TBL] [Abstract][Full Text] [Related]
25. Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau.
Ray B; Reyes PF; Lahiri DK
J Psychiatr Res; 2011 Apr; 45(4):539-47. PubMed ID: 20828718
[TBL] [Abstract][Full Text] [Related]
26. A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias.
Said HM; Kaya D; Yavuz I; Dost FS; Altun ZS; Isik AT
Clin Interv Aging; 2022; 17():467-477. PubMed ID: 35431542
[TBL] [Abstract][Full Text] [Related]
27. The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus.
Craven CL; Baudracco I; Zetterberg H; Lunn MPT; Chapman MD; Lakdawala N; Watkins LD; Toma AK
Acta Neurochir (Wien); 2017 Dec; 159(12):2293-2300. PubMed ID: 28889317
[TBL] [Abstract][Full Text] [Related]
28. Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus.
Brandner S; Thaler C; Lelental N; Buchfelder M; Kleindienst A; Maler JM; Kornhuber J; Lewczuk P
J Alzheimers Dis; 2014; 41(4):1057-62. PubMed ID: 24748118
[TBL] [Abstract][Full Text] [Related]
29. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.
Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM
JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of amyloid PET scan in normal pressure hydrocephalus.
Jang H; Park SB; Kim Y; Kim KW; Lee JI; Kim ST; Lee KH; Kang ES; Choe YS; Seo SW; Kim HJ; Kim YJ; Yoon CW; Na DL
J Neurol; 2018 Jan; 265(1):63-73. PubMed ID: 29128930
[TBL] [Abstract][Full Text] [Related]
31. Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.
Herukka SK; Rummukainen J; Ihalainen J; von Und Zu Fraunberg M; Koivisto AM; Nerg O; Puli LK; Seppälä TT; Zetterberg H; Pyykkö OT; Helisalmi S; Tanila H; Alafuzoff I; Hiltunen M; Rinne J; Soininen H; Jääskeläinen JE; Leinonen V
J Alzheimers Dis; 2015; 46(1):261-9. PubMed ID: 25720406
[TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients.
Lukkarinen H; Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Hiltunen M; Rauramaa T; Nägga K; Leinonen V; Tullberg M
Fluids Barriers CNS; 2022 Feb; 19(1):11. PubMed ID: 35123528
[TBL] [Abstract][Full Text] [Related]
33. Soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for differential diagnosis of mild cognitive impairment.
Araki W; Kanemaru K; Hattori K; Tsukamoto T; Saito Y; Yoshida S; Takano H; Sakata M; Yokoi Y; Omachi Y; Nagaoka U; Nagao M; Komori T; Tachimori H; Murayama S; Mizusawa H
Aging Clin Exp Res; 2022 Feb; 34(2):341-347. PubMed ID: 34283410
[TBL] [Abstract][Full Text] [Related]
34. Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease.
Alcolea D; Martínez-Lage P; Sánchez-Juan P; Olazarán J; Antúnez C; Izagirre A; Ecay-Torres M; Estanga A; Clerigué M; Guisasola MC; Sánchez Ruiz D; Marín Muñoz J; Calero M; Blesa R; Clarimón J; Carmona-Iragui M; Morenas-Rodríguez E; Rodríguez-Rodríguez E; Vázquez Higuera JL; Fortea J; Lleó A
Neurology; 2015 Aug; 85(7):626-33. PubMed ID: 26180139
[TBL] [Abstract][Full Text] [Related]
35. Association between ventricular CSF biomarkers and outcome after shunt surgery in idiopathic normal pressure hydrocephalus.
Grønning R; Jeppsson A; Hellström P; Laurell K; Farahmand D; Zetterberg H; Blennow K; Wikkelsø C; Tullberg M
Fluids Barriers CNS; 2023 Oct; 20(1):77. PubMed ID: 37880775
[TBL] [Abstract][Full Text] [Related]
36. Concordance of Alzheimer's Disease-Related Biomarkers Between Intraventricular and Lumbar Cerebrospinal Fluid in Idiopathic Normal Pressure Hydrocephalus.
Lukkarinen H; Vanninen A; Tesseur I; Pemberton D; Van Der Ark P; Kokkola T; Herukka SK; Rauramaa T; Hiltunen M; Blennow K; Zetterberg H; Leinonen V
J Alzheimers Dis; 2023; 91(1):305-319. PubMed ID: 36404546
[TBL] [Abstract][Full Text] [Related]
37. Change of Amyloid-β 1-42 Toxic Conformer Ratio After Cerebrospinal Fluid Diversion Predicts Long-Term Cognitive Outcome in Patients with Idiopathic Normal Pressure Hydrocephalus.
Akiba C; Nakajima M; Miyajima M; Ogino I; Motoi Y; Kawamura K; Adachi S; Kondo A; Sugano H; Tokuda T; Irie K; Arai H
J Alzheimers Dis; 2018; 63(3):989-1002. PubMed ID: 29710721
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal fluid amyloid beta and response of cognition to a tap test in idiopathic normal pressure hydrocephalus: a case-control study.
Kanemoto H; Mori E; Tanaka T; Suehiro T; Yoshiyama K; Suzuki Y; Kakeda K; Wada T; Hosomi K; Kishima H; Kazui H; Hashimoto M; Ikeda M
Int Psychogeriatr; 2023 Sep; 35(9):509-517. PubMed ID: 34399871
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid and venous biomarkers of shunt-responsive idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis.
Thavarajasingam SG; El-Khatib M; Vemulapalli KV; Iradukunda HAS; Laleye J; Russo S; Eichhorn C; Eide PK
Acta Neurochir (Wien); 2022 Jul; 164(7):1719-1746. PubMed ID: 35230552
[TBL] [Abstract][Full Text] [Related]
40. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.
Gisslén M; Krut J; Andreasson U; Blennow K; Cinque P; Brew BJ; Spudich S; Hagberg L; Rosengren L; Price RW; Zetterberg H
BMC Neurol; 2009 Dec; 9():63. PubMed ID: 20028512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
